Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sesen Bio Inc (NQ: SESN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sesen Bio Inc

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday. 
Via Benzinga
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
From Sesen Bio, Inc.
Via Business Wire
Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
From Sesen Bio, Inc.
Via Business Wire
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma
From Sesen Bio, Inc.
Via Business Wire
Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting
From Sesen Bio, Inc.
Via Business Wire
Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger
From Sesen Bio, Inc.
Via Business Wire
BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
From Sesen Bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger
From Sesen Bio, Inc.
Via Business Wire
Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger
From Sesen Bio, Inc.
Via Business Wire
Sesen Bio Receives NASDAQ Delisting Notice
From Sesen Bio, Inc.
Via Business Wire
Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders
From Sesen Bio, Inc.
Via Business Wire
Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support
From On behalf of Bradley L. Radoff
Via Business Wire
Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics
From Sesen Bio, Inc.
Via Business Wire
Investor Group Issues Letter to Sesen Bio’s Board of Directors Regarding Intent to Vote AGAINST Proposed Carisma Merger
From On behalf of Bradley L. Radoff
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sesen Bio, Inc. (Nasdaq - SESN), IsoPlexis (Nasdaq - ISO), Trean Insurance Group, Inc. (Nasdaq - TIG), Brunswick Bancorp (OTC – BRBW)
From Brodsky & Smith LLC
Via GlobeNewswire
Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics
From Sesen Bio, Inc.
Via Business Wire
Investor Group Reiterates Intent to Vote AGAINST Sesen Bio’s Value-Destructive Merger with Carisma
From On behalf of Bradley L. Radoff
Via Business Wire
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday. 
Via Benzinga
Why Sesen Bio Shares Are Skyrocketing Friday?
Sesen Bio Inc (NASDAQ: SESN) shares are trading higher by 16.81% to $0.59 Friday morning after the company and Carisma Therapeutics announced an increased special dividend of $70 million, or $0.34 per... 
Via Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the... 
Via Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to... 
Via Benzinga
Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday
With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger
From Sesen Bio, Inc.
Via Business Wire
Sesen Bio: Q3 Earnings Insights
Sesen Bio (NASDAQ:SESN) reported its Q3 earnings results on Monday, November 7, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Sesen Bio beat estimated earnings... 
Via Benzinga
Sesen Bio Reports Third Quarter 2022 Financial Results and Business Update
From Sesen Bio
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.